174 related articles for article (PubMed ID: 19270829)
1. Factors associated with HIV-1 proviral DNA loads in patients with undetectable plasma RNA load.
Choi JY; Song YG; Kim YH; Kim CO; Kim MS; Chin BS; Han SH; Choi SH; Lee HS; Jeong SJ; Choi H; Kim JM
J Korean Med Sci; 2009 Feb; 24(1):152-4. PubMed ID: 19270829
[TBL] [Abstract][Full Text] [Related]
2. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N
J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect.
Montoya JG; Wood R; Katzenstein D; Holodny M; Merigan TC
J Clin Microbiol; 1993 Oct; 31(10):2692-6. PubMed ID: 7902845
[TBL] [Abstract][Full Text] [Related]
5. Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy.
Debiaggi M; Zara F; Pistorio A; Bruno R; Sacchi P; Patruno SF; Achilli G; Romero E; Filice G
Int J Infect Dis; 2000; 4(4):187-93. PubMed ID: 11231180
[TBL] [Abstract][Full Text] [Related]
6. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.
Chege D; Kovacs C; la Porte C; Ostrowski M; Raboud J; Su D; Kandel G; Brunetta J; Kim CJ; Sheth PM; Kaul R; Loutfy MR
AIDS; 2012 Jan; 26(2):167-74. PubMed ID: 22089379
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 DNA burden in peripheral blood CD4+ cells influences disease progression, antiretroviral efficacy, and CD4+ T-cell restoration.
Russell RR; Bowmer MI; Nguyen C; Grant MD
Viral Immunol; 2001; 14(4):379-89. PubMed ID: 11792067
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR.
Kabamba-Mukadi B; Henrivaux P; Ruelle J; Delferrière N; Bodéus M; Goubau P
BMC Infect Dis; 2005 Mar; 5():15. PubMed ID: 15780144
[TBL] [Abstract][Full Text] [Related]
9. Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy.
Andreoni M; Parisi SG; Sarmati L; Nicastri E; Ercoli L; Mancino G; Sotgiu G; Mannazzu M; Trevenzoli M; Tridente G; Concia E; Aceti A
AIDS; 2000 Jan; 14(1):23-9. PubMed ID: 10714564
[TBL] [Abstract][Full Text] [Related]
10. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay.
Désiré N; Dehée A; Schneider V; Jacomet C; Goujon C; Girard PM; Rozenbaum W; Nicolas JC
J Clin Microbiol; 2001 Apr; 39(4):1303-10. PubMed ID: 11283046
[TBL] [Abstract][Full Text] [Related]
11. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
Ostrowski SR; Katzenstein TL; Thim PT; Pedersen BK; Gerstoft J; Ullum H
J Infect Dis; 2005 Feb; 191(3):348-57. PubMed ID: 15633093
[TBL] [Abstract][Full Text] [Related]
12. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
Dornadula G; Nunnari G; Vanella M; Roman J; Babinchak T; DeSimone J; Stern J; Braffman M; Zhang H; Pomerantz RJ
J Infect Dis; 2001 Jun; 183(11):1682-7. PubMed ID: 11343220
[TBL] [Abstract][Full Text] [Related]
15. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.
Vitone F; Gibellini D; Schiavone P; Re MC
J Clin Virol; 2005 Jul; 33(3):194-200. PubMed ID: 15911440
[TBL] [Abstract][Full Text] [Related]
16. Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy.
Ngo-Giang-Huong N; Deveau C; Da Silva I; Pellegrin I; Venet A; Harzic M; Sinet M; Delfraissy JF; Meyer L; Goujard C; Rouzioux C;
AIDS; 2001 Apr; 15(6):665-73. PubMed ID: 11371680
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease.
Verhofstede C; Reniers S; Van Wanzeele F; Plum J
AIDS; 1994 Oct; 8(10):1421-7. PubMed ID: 7529507
[TBL] [Abstract][Full Text] [Related]
18. Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART.
Baldanti F; Paolucci S; Gulminetti R; Maserati R; Migliorino G; Pan A; Maggiolo F; Comolli G; Chiesa A; Gerna G
Antiviral Res; 2001 Jun; 50(3):197-206. PubMed ID: 11397507
[TBL] [Abstract][Full Text] [Related]
19. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
[TBL] [Abstract][Full Text] [Related]
20. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients.
Ibáñez A; Puig T; Elias J; Clotet B; Ruiz L; Martínez MA
AIDS; 1999 Jun; 13(9):1045-9. PubMed ID: 10397534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
